Low frequency of p53 gene mutation and protein expression in mucinous colorectal carcinomas.
Immunohistochemical data indicate that the frequency of p53 protein overexpression is consistently lower in the mucinous than in the non-mucinous carcinomas of the breast, ovary, pancreas and colon. This peculiar immunohistochemical behavior of the mucinous phenotype could be due to the effect of large amounts of mucus on the staining or to an actual mutation frequency difference between mucinous and non-mucinous carcinomas. This question was investigated on a group of mucinous colorectal carcinomas. DNA was extracted from paraffin sections of 16 human mucinous colorectal carcinomas and the mutation frequency was determined by sequencing of p53 exons amplified in PCR. The expression of p53 protein was determined with the avidin-biotin complex-peroxidase staining procedure and CM-1 antiserum. Twenty-five percent of the tumors, exhibited p53 protein overexpression and in 31% a mutation was detected. Concordance between the two techniques was found in 69% of tumors. Overexpression without mutation was observed in 12% and mutation without overexpression in 19%. G:C --> A:T transitions represented the most frequent lesion (80%), as previously observed in non-mucinous colorectal carcinomas. These data indicate that the mutation pattern in the p53 gene is similar in mucinous and non-mucinous colorectal carcinomas. The low frequency of p53 overexpression in the mucinous phenotype is not due to a mucus effect on the staining but is related to the low mutation frequency of p53 gene. These results lead to the hypothesis that in contrast to the nonmucinous tumors the development of the majority of colonic carcinomas with the mucinous phenotype may be independent from p53 mutations.
Hanski
C
C
Department of Gastroenterology, Klinikum Benjamin Franklin der Freien Universität Berlin, Germany.
Tiecke
F
F
Hummel
M
M
Hanski
M L
ML
Ogorek
D
D
Rolfs
A
A
Schmitt-Gräff
A
A
Stein
H
H
Riecken
E O
EO
D002288:Adenocarcinoma, Mucinous / Q000235:genetics / Q000378:metabolism*; D001483:Base Sequence; D015179:Colorectal Neoplasms / Q000235:genetics / Q000378:metabolism*; D017931:DNA Primers / Q000737:chemistry; D016158:Genes, p53; D006801:Humans; D007124:Immunoenzyme Techniques; D008969:Molecular Sequence Data; D009154:Mutation; D017354:Point Mutation; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
D017931:DNA Primers; D016159:Tumor Suppressor Protein p53